Clinical Trial Update: Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating palbociclib in combination with an aromatase inhibitor or fulvestrant in women with advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: iOMEDICO AG | Conditions: Breast Cancer, Hormone Receptor Positive Tumor | Phase 2 | Status: COMPLETED